Topical Intra-Oral Ketoprofen for Migraine Prevention

Summary

Intra-Oral Topical Ketoprofen gel, applied to a branch of the trigeminal nerve, has been shown to prevent migraines when used once daily for 3 months in open label studies. This is a randomized, double-blind, placebo controlled phase III prevention trial to determine safety and efficacy.

Timeline

Start

2009-10

Primary completion

2011-06

Completion

2011-06

Drugs

Indications